share_log

Laboratory Corp Analyst Ratings

Laboratory Corp Analyst Ratings

实验室公司分析师评级
Benzinga ·  2023/09/18 13:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/18/2023 17.65% Baird $251 → $237 Maintains Outperform
09/15/2023 34.03% Truist Securities → $270 Reiterates Buy → Buy
09/15/2023 27.58% Mizuho → $257 Reiterates Buy → Buy
09/06/2023 4.25% HSBC → $210 Initiates Coverage On → Hold
08/14/2023 34.03% Wells Fargo $290 → $270 Maintains Overweight
08/03/2023 29.07% Morgan Stanley $285 → $260 Maintains Overweight
08/02/2023 14.67% Credit Suisse $247.41 → $231 Maintains Outperform
07/31/2023 24.6% Baird $255 → $251 Maintains Outperform
07/28/2023 34.03% Truist Securities $275 → $270 Maintains Buy
06/05/2023 42.97% Credit Suisse → $288 Reiterates Outperform → Outperform
05/16/2023 27.58% Mizuho $277 → $257 Maintains Buy
05/10/2023 41.48% Morgan Stanley $295 → $285 Maintains Overweight
05/01/2023 36.52% Truist Securities $285 → $275 Maintains Buy
03/13/2023 42.97% Credit Suisse $304 → $288 Maintains Outperform
02/21/2023 50.91% Credit Suisse $305 → $304 Maintains Outperform
02/21/2023 43.96% Wells Fargo $315 → $290 Maintains Overweight
02/17/2023 41.48% Truist Securities $275 → $285 Maintains Buy
02/17/2023 29.07% Citigroup $250 → $260 Maintains Neutral
02/17/2023 48.93% Baird $285 → $300 Maintains Outperform
02/17/2023 37.51% Mizuho $250 → $277 Maintains Buy
01/11/2023 41.48% Baird $270 → $285 Maintains Outperform
01/06/2023 50.42% Morgan Stanley $290 → $303 Maintains Overweight
12/12/2022 24.11% Citigroup → $250 Downgrades Buy → Neutral
11/23/2022 51.41% Credit Suisse $308 → $305 Maintains Outperform
11/03/2022 24.11% Mizuho $296 → $250 Maintains Buy
10/31/2022 43.96% Morgan Stanley $300 → $290 Maintains Overweight
10/28/2022 29.07% Truist Securities $275 → $260 Maintains Buy
08/22/2022 48.93% Morgan Stanley → $300 Assumes → Overweight
08/01/2022 52.9% Credit Suisse $312 → $308 Maintains Outperform
07/29/2022 46.94% Mizuho $323 → $296 Maintains Buy
05/25/2022 48.93% Morgan Stanley $360 → $300 Maintains Overweight
05/03/2022 31.55% Deutsche Bank $294 → $265 Maintains Hold
05/02/2022 54.88% Credit Suisse $344 → $312 Maintains Outperform
04/25/2022 56.37% Wells Fargo $320 → $315 Maintains Overweight
02/14/2022 78.71% Morgan Stanley $380 → $360 Maintains Overweight
02/11/2022 70.77% Credit Suisse $340 → $344 Maintains Outperform
01/28/2022 45.95% Deutsche Bank → $294 Downgrades Buy → Hold
12/20/2021 75.73% Mizuho $332 → $354 Maintains Buy
12/17/2021 88.64% Morgan Stanley $377 → $380 Maintains Overweight
12/14/2021 68.78% Wells Fargo $330 → $340 Maintains Overweight
11/01/2021 67.79% Credit Suisse $336 → $338 Maintains Outperform
10/29/2021 87.15% Morgan Stanley $368 → $377 Maintains Overweight
08/31/2021 82.68% Morgan Stanley $273 → $368 Maintains Overweight
08/20/2021 66.8% Credit Suisse $296 → $336 Maintains Outperform
08/19/2021 64.81% Mizuho $318 → $332 Maintains Buy
07/30/2021 63.82% Deutsche Bank $297 → $330 Maintains Buy
07/30/2021 57.86% Mizuho $310 → $318 Maintains Buy
05/20/2021 46.45% Argus Research $270 → $295 Maintains Buy
05/12/2021 53.89% Mizuho $267 → $310 Maintains Buy
05/03/2021 53.89% Jefferies $300 → $310 Maintains Buy
04/14/2021 48.93% Truist Securities $280 → $300 Maintains Buy
02/12/2021 32.55% Mizuho $242 → $267 Maintains Buy
02/12/2021 38.01% Citigroup $257 → $278 Maintains Buy
01/29/2021 27.58% Citigroup $249 → $257 Maintains Buy
01/14/2021 20.14% Mizuho $234 → $242 Maintains Buy
01/11/2021 — Argus Research Upgrades Hold → Buy
10/28/2020 29.07% Wells Fargo $225 → $260 Maintains Overweight
07/29/2020 19.14% B of A Securities $220 → $240 Maintains Buy
07/14/2020 9.21% B of A Securities $194 → $220 Upgrades Neutral → Buy
07/13/2020 7.72% Wolfe Research $202 → $217 Upgrades Peer Perform → Outperform
06/08/2020 8.72% Baird $199 → $219 Maintains Outperform
06/02/2020 4.25% Deutsche Bank → $210 Reinstates → Buy
05/21/2020 9.21% SunTrust Robinson Humphrey $200 → $220 Maintains Buy
05/20/2020 21.13% Morgan Stanley $241 → $244 Maintains Overweight
05/15/2020 -7.66% Mizuho $158 → $186 Upgrades Neutral → Buy
05/05/2020 8.22% UBS $209 → $218 Maintains Buy
04/30/2020 19.64% Morgan Stanley $172 → $241 Maintains Overweight
04/30/2020 -5.68% B of A Securities $147 → $190 Reiterates → Neutral
04/27/2020 6.24% Citigroup $204 → $214 Upgrades Neutral → Buy
04/23/2020 -3.2% Barclays $188 → $195 Maintains Overweight
04/16/2020 -21.56% Mizuho $163 → $158 Maintains Neutral
04/13/2020 -0.71% SunTrust Robinson Humphrey $225 → $200 Maintains Buy
04/08/2020 -14.61% Morgan Stanley $211 → $172 Maintains Overweight
04/02/2020 -26.03% JP Morgan $149 → $149 Maintains Overweight
03/30/2020 -15.61% Wells Fargo $215 → $170 Maintains Overweight
03/30/2020 -15.61% Keybanc $212 → $170 Maintains Overweight
03/26/2020 -6.67% Barclays $212 → $188 Maintains Overweight
02/25/2020 -5.68% Mizuho $174 → $190 Maintains Neutral
02/18/2020 4.75% Morgan Stanley $199 → $211 Maintains Overweight
02/14/2020 1.27% Citigroup $179 → $204 Maintains Neutral
01/08/2020 4.25% Wells Fargo → $210 Initiates Coverage On → Overweight
10/21/2019 -0.71% UBS $204 → $200 Maintains Buy
08/23/2019 -0.22% Morgan Stanley $190 → $201 Maintains Overweight
08/08/2019 -4.69% Keybanc $172 → $192 Maintains Overweight
07/26/2019 -5.68% Morgan Stanley $175 → $190 Maintains Overweight
07/16/2019 — B of A Securities Upgrades Underperform → Neutral
06/21/2019 9.21% Deutsche Bank $180 → $220 Upgrades Hold → Buy
05/02/2019 -18.09% Canaccord Genuity $155 → $165 Maintains Hold
05/01/2019 -12.63% Citigroup $157 → $176 Maintains Neutral
05/01/2019 -3.2% UBS $178 → $195 Maintains Buy
04/02/2019 — Jefferies Upgrades Hold → Buy
03/18/2019 -14.12% Barclays $165 → $173 Maintains Overweight
02/27/2019 -18.59% Credit Suisse $160 → $164 Maintains Outperform
01/17/2019 -16.1% UBS → $169 Initiates Coverage On → Buy
01/03/2019 — B of A Securities Downgrades Neutral → Underperform
12/06/2018 -18.09% Keybanc $210 → $165 Maintains Overweight
12/03/2018 -18.09% Barclays $205 → $165 Maintains Overweight
12/03/2018 -20.57% Citigroup $171 → $160 Maintains Neutral
12/03/2018 -23.05% Canaccord Genuity $162 → $155 Maintains Hold
12/03/2018 -10.64% Morgan Stanley $202 → $180 Maintains Overweight
11/30/2018 -10.64% Goldman Sachs $190 → $180 Downgrades Conviction Buy → Buy
10/30/2018 — Argus Research Downgrades Buy → Hold
10/25/2018 -5.68% Baird $205 → $190 Maintains Outperform
10/25/2018 -15.11% Citigroup $184 → $171 Maintains Neutral
10/25/2018 -19.58% Canaccord Genuity $195 → $162 Downgrades Buy → Hold
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
09/18/2023 17.65% 贝尔德 $251→$237 维护 跑赢大盘
2023/09/15 34.03% Truist证券 →$270 重申 购买→购买
2023/09/15 27.58% 瑞穗 →$257 重申 购买→购买
09/06/2023 4.25% 汇丰银行 →$210 开始承保 →保留
2023年08月14日 34.03% 富国银行 $290→$270 维护 超重
08/03/2023 29.07% 摩根士丹利 $285→$260 维护 超重
08/02/2023 14.67% 瑞士信贷 $247.41→$231 维护 跑赢大盘
07/31/2023 24.6% 贝尔德 $255→$251 维护 跑赢大盘
07/28/2023 34.03% Truist证券 $275→$270 维护 买
06/05/2023 42.97% 瑞士信贷 →$288 重申 跑赢→跑赢大盘
2023年05月16日 27.58% 瑞穗 $277→$257 维护 买
2023年05月10日 41.48% 摩根士丹利 $295→$285 维护 超重
05/01/2023 36.52% Truist证券 $285→$275 维护 买
03/13/2023 42.97% 瑞士信贷 $304→$288 维护 跑赢大盘
02/21/2023 50.91% 瑞士信贷 $305→$304 维护 跑赢大盘
02/21/2023 43.96% 富国银行 $315→$290 维护 超重
02/17/2023 41.48% Truist证券 $275→$285 维护 买
02/17/2023 29.07% 花旗集团 $250→$260 维护 中性
02/17/2023 48.93% 贝尔德 $285→$300 维护 跑赢大盘
02/17/2023 37.51% 瑞穗 $250→$277 维护 买
2023年1月11日 41.48% 贝尔德 $270→$285 维护 跑赢大盘
01/06/2023 50.42% 摩根士丹利 $290→$303 维护 超重
2022年12月12日 24.11% 花旗集团 →$250 评级下调 购买→中性
2022年11月23日 51.41% 瑞士信贷 $308→$305 维护 跑赢大盘
11/03/2022 24.11% 瑞穗 $296→$250 维护 买
2022年10月31日 43.96% 摩根士丹利 $300→$290 维护 超重
10/28/2022 29.07% Truist证券 $275→$260 维护 买
2022/08/22 48.93% 摩根士丹利 →$300 假设 →超重
08/01/2022 52.9% 瑞士信贷 $312→$308 维护 跑赢大盘
07/29/2022 46.94% 瑞穗 $323→$296 维护 买
2022年05月25日 48.93% 摩根士丹利 $360→$300 维护 超重
05/03/2022 31.55% 德意志银行 $294→$265 维护 保持
05/02/2022 54.88% 瑞士信贷 $344→$312 维护 跑赢大盘
04/25/2022 56.37% 富国银行 $320→$315 维护 超重
02/14/2022 78.71% 摩根士丹利 $380→$360 维护 超重
02/11/2022 70.77% 瑞士信贷 $340→$344 维护 跑赢大盘
2022年01月28日 45.95% 德意志银行 →$294 评级下调 购买→Hold
12/20/2021 75.73% 瑞穗 $332→$354 维护 买
2021/12/17 88.64% 摩根士丹利 $377→$380 维护 超重
2021年12月14日 68.78% 富国银行 $330→$340 维护 超重
11/01/2021 67.79% 瑞士信贷 $336→$338 维护 跑赢大盘
10/29/2021 87.15% 摩根士丹利 $368→$377 维护 超重
2021/08/31 82.68% 摩根士丹利 $273→$368 维护 超重
08/20/2021 66.8% 瑞士信贷 $296→$336 维护 跑赢大盘
2021/08/19 64.81% 瑞穗 $318→$332 维护 买
07/30/2021 63.82% 德意志银行 $297→$330 维护 买
07/30/2021 57.86% 瑞穗 $310→$318 维护 买
05/20/2021 46.45% Argus研究 $270→$295 维护 买
2021/05/12 53.89% 瑞穗 $267→$310 维护 买
05/03/2021 53.89% 杰富瑞 $300→$310 维护 买
04/14/2021 48.93% Truist证券 $280→$300 维护 买
02/12/2021 32.55% 瑞穗 $242→$267 维护 买
02/12/2021 38.01% 花旗集团 $257→$278 维护 买
2021/01/29 27.58% 花旗集团 $249→$257 维护 买
2021/01/14 20.14% 瑞穗 $234→$242 维护 买
2021/11/01 - Argus研究 升级 持有→购买
10/28/2020 29.07% 富国银行 $225→$260 维护 超重
07/29/2020 19.14% B of A证券 $220→$240 维护 买
07/14/2020 9.21% B of A证券 $194→$220 升级 中性→购买
07/13/2020 7.72% 沃尔夫研究 $202→$217 升级 同业表现优于→
06/08/2020 8.72% 贝尔德 $199→$219 维护 跑赢大盘
06/02/2020 4.25% 德意志银行 →$210 恢复 →购买
2020/05/21 9.21% SunTrust Robinson Humphrey $200→$220 维护 买
05/20/2020 21.13% 摩根士丹利 $241→$244 维护 超重
2020/05/15 -7.66% 瑞穗 $158→$186 升级 中性→购买
05/05/2020 8.22% 瑞银集团 $209→$218 维护 买
04/30/2020 19.64% 摩根士丹利 $172→$241 维护 超重
04/30/2020 -5.68% B of A证券 $147→$190 重申 →中性
04/27/2020 6.24% 花旗集团 $204→$214 升级 中性→购买
04/23/2020 -3.2% 巴克莱 $188→$195 维护 超重
04/16/2020 -21.56% 瑞穗 $163→$158 维护 中性
04/13/2020 -0.71% SunTrust Robinson Humphrey $225→$200 维护 买
04/08/2020 -14.61% 摩根士丹利 $211→$172 维护 超重
04/02/2020 -26.03% 摩根大通 $149→$149 维护 超重
03/30/2020 -15.61% 富国银行 $215→$170 维护 超重
03/30/2020 -15.61% KeyBanc $212→$170 维护 超重
03/26/2020 -6.67% 巴克莱 $212→$188 维护 超重
02/25/2020 -5.68% 瑞穗 $174→$190 维护 中性
02/18/2020 4.75% 摩根士丹利 $199→$211 维护 超重
02/14/2020 1.27% 花旗集团 $179→$204 维护 中性
1/08/2020 4.25% 富国银行 →$210 开始承保 →超重
2019年10月21日 -0.71% 瑞银集团 $204→$200 维护 买
2019年08月23日 -0.22% 摩根士丹利 $190→$201 维护 超重
2019年08月08日 -4.69% KeyBanc $172→$192 维护 超重
2019年07月26日 -5.68% 摩根士丹利 $175→$190 维护 超重
2019年07月16日 - B of A证券 升级 表现不佳的→中性
2019年06月21日 9.21% 德意志银行 $180→$220 升级 持有→购买
2019年05月02日 -18.09% 卡纳科特·格纳奇 $155→$165 维护 保持
2019年05月01日 -12.63% 花旗集团 $157→$176 维护 中性
2019年05月01日 -3.2% 瑞银集团 $178→$195 维护 买
2019年02月04日 - 杰富瑞 升级 持有→购买
2019/03/18 -14.12% 巴克莱 $165→$173 维护 超重
2019年02月27日 -18.59% 瑞士信贷 $160→$164 维护 跑赢大盘
2019年01月17日 -16.1% 瑞银集团 →$169 开始承保 →购买
2019年03月01日 - B of A证券 评级下调 中性→表现不佳
2018年12月06日 -18.09% KeyBanc $210→$165 维护 超重
12/03/2018 -18.09% 巴克莱 $205→$165 维护 超重
12/03/2018 -20.57% 花旗集团 $171→$160 维护 中性
12/03/2018 -23.05% 卡纳科特·格纳奇 $162→$155 维护 保持
12/03/2018 -10.64% 摩根士丹利 $202→$180 维护 超重
2018年11月30日 -10.64% 高盛 $190→$180 评级下调 定罪购买→购买
2018年10月30日 - Argus研究 评级下调 购买→Hold
2018年10月25日 -5.68% 贝尔德 $205→$190 维护 跑赢大盘
2018年10月25日 -15.11% 花旗集团 $184→$171 维护 中性
2018年10月25日 -19.58% 卡纳科特·格纳奇 $195→$162 评级下调 购买→Hold

What is the target price for Laboratory Corp (LH)?

实验室公司(LH)的目标价格是多少？

The latest price target for Laboratory Corp (NYSE: LH) was reported by Baird on September 18, 2023. The analyst firm set a price target for $237.00 expecting LH to rise to within 12 months (a possible 17.65% upside). 27 analyst firms have reported ratings in the last year.

Baird于2023年9月18日报道了实验室公司(纽约证券交易所代码：LH)的最新目标价。这家分析公司将目标价定为237.00美元，预计LH将在12个月内上涨至17.65%(可能上涨17.65%)。去年有27家分析公司公布了评级。

What is the most recent analyst rating for Laboratory Corp (LH)?

实验室公司(实验室)的最新分析师评级是多少？

The latest analyst rating for Laboratory Corp (NYSE: LH) was provided by Baird, and Laboratory Corp maintained their outperform rating.

Baird提供了对实验室公司(纽约证券交易所代码：LH)的最新分析师评级，实验室公司维持了其表现优于大盘的评级。

When is the next analyst rating going to be posted or updated for Laboratory Corp (LH)?

实验室公司(LH)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Laboratory Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Laboratory Corp was filed on September 18, 2023 so you should expect the next rating to be made available sometime around September 18, 2024.

分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与实验室公司的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。实验室公司的上一次评级是在2023年9月18日提交的，所以你应该预计下一次评级将在2024年9月18日左右的某个时候公布。

Is the Analyst Rating Laboratory Corp (LH) correct?

分析师评级实验室公司(LH)是正确的吗？

While ratings are subjective and will change, the latest Laboratory Corp (LH) rating was a maintained with a price target of $251.00 to $237.00. The current price Laboratory Corp (LH) is trading at is $201.44, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的实验室公司(LH)评级保持不变，目标价在251.00美元至237.00美元之间。实验室公司目前的交易价格是201.44美元，超出了分析师的预测范围。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发